Home
Scholarly Works
Effect of Benralizumab Versus Mepolizumab on...
Conference

Effect of Benralizumab Versus Mepolizumab on Reduction in Oral Glucocorticoid Use in Patients With Eosinophilic Granulomatosis With Polyangiitis: Phase 3 MANDARA Study

Authors

Nair P; Wechsler ME; Bourdin A; Merkel PA; Hellmich B; Jayne DRW; Börjesson Sjö L; Fan Y; Menzies-Gow A; Necander S

Pagination

pp. a6708-a6708

Publisher

Oxford University Press (OUP)

Publication Date

May 1, 2024

DOI

10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a6708

Name of conference

C102. CLINICAL AND TRANSLATIONAL ADVANCES IN ASTHMA
View published work (Non-McMaster Users)

Contact the Experts team